Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gabriela S Ene"'
Autor:
Gabriela Bastidas, Katia Flores, Erik Johansson, Alessandra Comai, Desirée Campoy, Silvia Ruiz, Tania Canals, Gabriela S Ene, Jorge Sierra, Pável E Olivera, Gonzalo Artaza, César A Velasquez, Maricel Subirá, Ramón Salinas
Publikováno v:
Blood. 134:3661-3661
BACKGROUND Non Valvular Atrial Fibrillation (NVAF) is the most common cardiac arrhythmia among patients with cancer. Anticoagulation in this setting is associated with a higher rate of clinically relevant major and non-major bleeding and therefore, c
Autor:
César A Velasquez, Ramón Salinas, Gabriela S Ene, Alessandra Comai, Maricel Subirá, Desirée Campoy, Silvia Ruiz, Tania Canals, Jorge Sierra, Katia Flores, Pável E Olivera, Gonzalo Artaza, Gabriela Bastidas, Erik Johansson
Publikováno v:
Blood. 134:1162-1162
BACKGROUND Direct oral anticoagulants (DOAC) are increasingly used in patients with Non Valvular Atrial Fibrillation (NVAF) for stroke prevention. However, Follow-Up (FU) and dosing these agents in the elderly can be challenging due to different fact
Autor:
Tania Canals, Gabriela S Ene, Katia Flores, César A Velasquez, Pável E Olivera, Gonzalo Artaza, Jorge Sierra, Desirée Campoy, Ramón Salinas, Sofía Vila, Maricel Subirá
Publikováno v:
Blood. 132:1254-1254
BACKGROUND The patients with venous thromboembolism (VTE) and thrombophilia have historically been treated with vitamin K antagonist (VKA) therapy. Nowadays, direct oral anticoagulants (DOAC) are broadly used in the treatment and prevention of VTE. H
Autor:
Tania Canals, Cristina Marzo, Pável E Olivera, Laura Vicente, Artur Oliver, Maria Cerda, Anna Bustins, Germán Las Heras, Esther Plensa, Marc Sorigue, Amparo Santamaría, Anna Varela, Desirée Campoy, Granada Perea, Erik Johansson, Eva Sánchez, M. Reyes Aguinaco, Mireia Constans, Carmen Jiménez, Verónica Pons, Meritxell López, Joan Carles Reverter, Gabriela S Ene, Nazly Santos, Angel Moya M.D., Dolors Tàssies, Miren Gabilondo, José Mateo
Publikováno v:
Medicina Clínica. 151:210.e1-210.e13
Resumen Antecedentes y objetivos En los ultimos anos los anticoagulantes orales directos (ACOD) se han convertido en una alternativa a los antagonistas de la vitamina K (AVK) para la prevencion del ictus y embolia sistemica en pacientes con fibrilaci